Recludix Pharma
Donglim Esther Park has worked in a number of roles in the scientific field since 2010. Donglim Esther began their career as a Research Associate at the University of Minnesota in 2010, before continuing their studies at Harvard University as a Doctoral Student from 2012 to 2019. Donglim Esther then moved on to the University of California San Diego in 2019, where they worked as a Postdoctoral Researcher. Most recently, they have been working as a Senior Scientist and Scientist at Recludix Pharma since 2021.
Donglim Esther Park attended the University of Minnesota from 2010 to 2012, where they obtained a Bachelor of Science in Microbiology, General. Donglim Esther then attended Harvard University from 2012 to 2019.
Recludix Pharma
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom generated DNA-encoded libraries, massively parallel determination of structure activity relationships, and a proprietary screening tool to ensure selectivity.